why choose us

First received: November 11, 2024

Clinical Trial: Dexmedetomidine for Improved Pain Relief and Recovery in Spine Surgery

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Pain, Postoperative

Study Type: INTERVENTIONAL


Official Title: Optimal-dose of Dexmedetomidine as Adjuvant to Epidural Local Anesthetic/Steroid Injectate to Improve Pain and Quality of Waking in Patients With Chronic Low Back Pain: A Randomized Case-control

Brief Summary: Chronic low back pain (CLBP) is a prevalent condition causing significant pain, disability, and reduced quality of life.While various treatments like exercise, NSAIDs, and spinal manipulation are recommended, their effectiveness is limited.Epidural steroid injections can provide short-term relief but may not be cost-effective and have associated risks.Dexmedetomidine (DXM) is a selective ?2-adrenergic agonist with analgesic properties.It has been used as an adjuvant to anesthetics and analgesics to enhance pain…

Read more